Security key
45779A846
InspireMD, Inc. - Common Stock, par value $0.0001 per share (NSPR)
CUSIP: 45779A846
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 48,244,715
- Total 13F shares
- 22,730,210
- Share change
- +8,668,305
- Total reported value
- $54,778,990
- Price per share
- $2.41
- Number of holders
- 40
- Value change
- +$20,913,736
- Number of buys
- 24
- Number of sells
- 8
Report period
Q3 2025
Institutions
40
Top holders
10
NSPR full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Previous quarter: Q2 2025
InspireMD, Inc. SEC filings
InspireMD, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 45779A846
Recent filing periods:
Ownership snapshot
Top shareholders of NSPR - InspireMD, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
MARSHALL WACE, LLP
13D/G signal
MARSHALL WACE, LLP
Evidence rows
42
Latest as of
30 Sep 2025
13D/G
13F
3/4/5
Lead comparable stake: 10%
13D/G row: MARSHALL WACE, LLP
Showing first 8 of 42 holder rows.
Open remaining rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| MARSHALL WACE, LLP |
13D/G
13F
Company
|
10%
|
$67,729,915
28,103,699 shares
|
$0 | 30 Sep 2025 |
| Michael A. Lawless |
13D/G
|
8.6%
|
$8,711,502
3,614,731 shares
|
$0 | 26 Jun 2025 |
| Parkman Healthcare Partners LLC |
13D/G
13F
Company
|
5.8%
|
$5,881,926
2,440,633 shares
|
$0 | 30 Sep 2025 |
| Nantahala Capital Partners Limited Partnership |
13D/G
|
5.7%
|
$5,827,419
2,418,016 shares
|
$0 | 30 Sep 2025 |
| Craig Shore |
13D/G
3/4/5
CFO and CAO
|
3.5%
|
$3,577,657
1,484,505 shares
|
$0 | 26 Jun 2025 |
| Nantahala Capital Management, LLC |
13F
Company
|
4.8%
|
$5,261,899
2,318,017 shares
|
— | 30 Jun 2025 |
| Rosalind Advisors, Inc. |
13F
Company
|
4.7%
|
$5,196,254
2,289,099 shares
|
— | 30 Jun 2025 |
| ORBIMED ADVISORS LLC |
13F
Company
|
4.4%
|
$4,842,829
2,133,405 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
40
Shares
22,730,210
Rows loaded
40
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
36
Q3 2025 holders
40
Holder diff
4
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend